Anti-SLAMF7 Recombinant Antibody (Elotuzumab) (CAT#: TAB-743)

Recombinant humanized antibody expressed in CHO binding to human SLAMF7/CD319. Elotuzumab is a humanized monoclonal antibody which is under phase III clinical investigation in relapsed multiple myeloma.

• Immunogen
• The details of the immunogen for this antibody are not available.

• Host Species
• Mouse

• Derivation
• Humanized (from mouse)

• Type
• IgG1 – kappa

• Species Reactivity
• Human

• Applications
• Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, IHC and most other immunological methods.

• CAS
• 915296-00-3

• Generic Name
• elotuzumab

• UNII
• 1351PE5UGS

• MW
• 145.5 kDa

• Related Disease
• Multiple myeloma (MM)

Author Profile

creative biolabs

Latest entries

Author Articles

• Tech30/08/2023Anti-CD3E Recombinant Antibody (Visilizumab) (CAT#: TAB-714)
• Tech30/08/2023Anti-SLAMF7 Recombinant Antibody (Elotuzumab) (CAT#: TAB-743)
• Tech30/08/2023Anti-Human MUC1 Recombinant Antibody (Sontuzumab) (CAT#: TAB-H65)
• Tech30/08/2023Anti-SELL/CD62L Recombinant Antibody (Aselizumab) (CAT#: TAB-720)